InspireMD Inc
NASDAQ:NSPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
InspireMD Inc
NASDAQ:NSPR
|
IL |
|
Pharmagest Interactive SA
F:PHF
|
FR |
|
ImExHS Ltd
ASX:IME
|
AU |
|
Panoramic Resources Ltd
ASX:PAN
|
AU |
|
OrganiGram Holdings Inc
TSX:OGI
|
CA |
|
Franklin Electric Co Inc
NASDAQ:FELE
|
US |
|
Brookfield Wealth Solutions Ltd
TSX:BNT
|
BM |
|
IRadimed Corp
NASDAQ:IRMD
|
US |
|
F
|
Feerum SA
WSE:FEE
|
PL |
|
S
|
Saigon Fuel JSC
VN:SFC
|
VN |
|
O
|
Oak Street Health Inc
F:HE6
|
US |
|
H
|
HocMon Trade JSC
VN:HTC
|
VN |
|
Paragon Care Ltd
ASX:PGC
|
AU |
|
Stevva Corp
OTC:STVA
|
GR |
|
Blue Ant Media Corp
TSX:BAMI
|
CA |
|
Incap Ltd
BSE:517370
|
IN |
|
R
|
R R Kabel Ltd
NSE:RRKABEL
|
IN |
Wall Street
Price Targets
NSPR Price Targets Summary
InspireMD Inc
According to Wall Street analysts, the average 1-year price target for
NSPR
is 5.1 USD
with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NSPR's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for
NSPR
is 5.1 USD
with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
What is InspireMD Inc's Revenue forecast?
Projected CAGR
63%
For the last 12 years the
compound annual growth rate for
InspireMD Inc's revenue is
3%.
The projected
CAGR
for the next 3 years is
63%.
